| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025992 |
| Receipt No. | R000029758 |
| Official scientific title of the study | A clinical study for evaluating the effects of P-chondroitin NHZ on knee joint symptoms |
| Date of disclosure of the study information | 2018/07/31 |
| Last modified on | 2019/02/06 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A clinical study for evaluating the effects of P-chondroitin NHZ on knee joint symptoms | |
| Title of the study (Brief title) | Effects of P-chondroitin NHZ on knee joint symptoms | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effects of P-chondroitin NHZ intake for 12 weeks on knee joint symptoms |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | JKOM and VAS (pain, stiffness and discomfort of the knee) |
| Key secondary outcomes | JOA score |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of tablets containing P-chondroitin for 12 weeks | |
| Interventions/Control_2 | Intake of tablets that don't contain P-chondroitin (placebo) for 12 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Subject, aged from 30 to 65 years males and females with pain of knee
2) Subject, be diagnosed KLgrade 0 or 1 3) Subject, upon briefing of the content of the present study, fully understanding and agreeing to its objective; and being able to personally sign a written informed consent |
|||
| Key exclusion criteria | 1)Subjects having a medical history of rheumatism
2)Subjects who have leg pain or numbness 3)Subjects who have injury of semi-lunar disc or the other knee joint disease 4) Subjects receiving treatment for osteoarthritis 5) Subject receiving treatment for serious liver, renal, cardio-vascular, respiratory, endocrine, or metabolic disorders 6) Subject presenting known allergy or history of pork 7) For female subject: pregnancy or breast feeding, or possibility of pregnancy, or intention to be pregnant during the study 8) Subject having blood sample of 200 ml or more taken (e.g., donated blood) within 1 month, or 400 ml or more within 3 months prior to the start of the present study 9) Subject who took part in another clinical trial within 3 months prior to the start of the present study or who is currently taking part in another clinical trial 10) Subject deemed unsuitable by the investigator |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Osami Kajimoto |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Department of Medical Science on Fatigue |
| Address | 1-4-3 Asahimachi, Abeno-ku, Osaka |
| TEL | 06-6645-6171 |
| kajimoto@med.osaka-cu.ac.jp | |
| Public contact | |
| Name of contact person | Tomohiro Sugino |
| Organization | Soiken Inc. |
| Division name | Representative Director |
| Address | Senri Life Science Center 13F, 1-4-2, Shinsenri-higashimachi,Toyonaka,Osaka |
| TEL | 06-6871-8888 |
| Homepage URL | |
| sugino@soiken.com | |
| Sponsor | |
| Institute | Soiken Inc. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | NH Foods Ltd. Research and Development Center |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人弘正会ふくだ内科クリニック |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029758 |